Literature DB >> 27222640

Relationship Between Depression and Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.

Claire Dunphy1, Leanna Laor1, Alexis Te1, Steven Kaplan1, Bilal Chughtai1.   

Abstract

This article provides an overview of current data on the relationship between depression and lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH), with a focus on pathophysiology and patient management implications. Review of the literature indicated a clear relationship between LUTS secondary to BPH and depression. It is unknown whether this relationship is bidirectional or unidirectional. Depression is associated with the impact of LUTS on quality of life in men with BPH. Research suggests that depression alters the experience of LUTS in this population. Medical and surgical treatments for BPH may impact quality of life and, therefore, depression. Results conflict on the exact nature of the relationship examined, and on the extent to which the relationship may be attributed to physiological factors such as inflammation. Practicing clinicians should consider using a brief self-administered scale to assess for depression in patients with BPH. There is a clear need for additional research to decisively determine the nature of the relationship between LUTS secondary to BPH and depression, as well as the extent to which change in either condition may be affected by the other.

Entities:  

Keywords:  Benign prostatic hyperplasia; Depression; Lower urinary tract symptoms

Year:  2015        PMID: 27222640      PMCID: PMC4857895          DOI: 10.3909/riu0658

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  22 in total

1.  Risk factors for progression or improvement of lower urinary tract symptoms in a prospective cohort of men.

Authors:  Sean Martin; Kylie Lange; Matthew T Haren; Anne W Taylor; Gary Wittert
Journal:  J Urol       Date:  2013-06-11       Impact factor: 7.450

2.  Update on AUA guideline on the management of benign prostatic hyperplasia.

Authors:  Kevin T McVary; Claus G Roehrborn; Andrew L Avins; Michael J Barry; Reginald C Bruskewitz; Robert F Donnell; Harris E Foster; Chris M Gonzalez; Steven A Kaplan; David F Penson; James C Ulchaker; John T Wei
Journal:  J Urol       Date:  2011-03-21       Impact factor: 7.450

3.  Increased risk of depressive disorder following the diagnosis of benign prostatic enlargement: one-year follow-up study.

Authors:  Chao-Yuan Huang; Kuan-Ming Chiu; Shiu-Dong Chung; Joseph J Keller; Chung-Chien Huang; Herng-Ching Lin
Journal:  J Affect Disord       Date:  2011-08-06       Impact factor: 4.839

4.  Drug or symptom-induced depression in men treated with alpha 1-blockers for benign prostatic hyperplasia? A nested case-control study.

Authors:  Gary M Clifford; Richard D T Farmer
Journal:  Pharmacoepidemiol Drug Saf       Date:  2002 Jan-Feb       Impact factor: 2.890

5.  Major depression drives severity of American Urological Association Symptom Index.

Authors:  Timothy V Johnson; Ammara Abbasi; Samantha S Ehrlich; Renee S Kleris; Siri L Chirumamilla; Evan D Schoenberg; Ashli Owen-Smith; Charles L Raison; Viraj A Master
Journal:  Urology       Date:  2010-12       Impact factor: 2.649

Review 6.  Mental depression and cardiovascular disease: a multifaceted, bidirectional association.

Authors:  Giuseppe Lippi; Martina Montagnana; Emmanuel J Favaloro; Massimo Franchini
Journal:  Semin Thromb Hemost       Date:  2009-05-18       Impact factor: 4.180

Review 7.  Depression and cancer: mechanisms and disease progression.

Authors:  David Spiegel; Janine Giese-Davis
Journal:  Biol Psychiatry       Date:  2003-08-01       Impact factor: 13.382

8.  Lower urinary tract symptoms are associated with depressive symptoms in white, black and Hispanic men in the United States.

Authors:  Edward O Laumann; Jeong-han Kang; Dale B Glasser; Raymond C Rosen; Culley C Carson
Journal:  J Urol       Date:  2008-05-21       Impact factor: 7.450

9.  Lower urinary tract symptoms and depression.

Authors:  Maximilian Rom; Georg Schatzl; Natalia Swietek; Ernst Rücklinger; Christian Kratzik
Journal:  BJU Int       Date:  2012-10-26       Impact factor: 5.588

10.  The association of lower urinary tract symptoms, depression and suicidal ideation: data from the 2005-2006 and 2007-2008 National Health and Nutrition Examination Survey.

Authors:  Benjamin N Breyer; Stacey A Kenfield; Sarah D Blaschko; Bradley A Erickson
Journal:  J Urol       Date:  2013-12-14       Impact factor: 7.450

View more
  20 in total

1.  [Treatment of benign prostatic hyperplasia using convective radiofrequency water vapour thermal therapy].

Authors:  A Sigle; A Miernik
Journal:  Urologe A       Date:  2021-02-01       Impact factor: 0.639

2.  Association of Suicidality and Depression With 5α-Reductase Inhibitors.

Authors:  Blayne Welk; Eric McArthur; Michael Ordon; Kelly K Anderson; Jade Hayward; Stephanie Dixon
Journal:  JAMA Intern Med       Date:  2017-05-01       Impact factor: 21.873

3.  Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.

Authors:  Jae Hung Jung; Balaji Reddy; Karen Ann McCutcheon; Michael Borofsky; Vikram Narayan; Myung Ha Kim; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2019-05-25

Review 4.  Marijuana, Alcohol, and ED: Correlations with LUTS/BPH.

Authors:  Granville L Lloyd; Brett Wiesen; Mike Atwell; Anna Malykhina
Journal:  Curr Urol Rep       Date:  2021-02-08       Impact factor: 3.092

5.  Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.

Authors:  Eu Chang Hwang; Jae Hung Jung; Michael Borofsky; Myung Ha Kim; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2019-02-13

6.  [Minimally invasive treatment for symptoms of the lower urinary tract in men with benign prostatic hyperplasia: a network meta-analysis].

Authors:  Sandra Schönburg
Journal:  Urologie       Date:  2022-09-09

7.  A possible mechanism underlying mood disorders associated with LUTS: Chronic bladder outlet obstruction causes NLRP3-dependent inflammation in the hippocampus and depressive behavior in rats.

Authors:  Francis M Hughes; Nathan A Hirshman; Hamza A Malick; Simon W White; Huixia Jin; Shelby N Harper; J Todd Purves
Journal:  Neurourol Urodyn       Date:  2020-06-29       Impact factor: 2.696

8.  Cyclophosphamide-induced cystitis results in NLRP3-mediated inflammation in the hippocampus and symptoms of depression in rats.

Authors:  Nathan A Hirshman; Francis M Hughes; Huixia Jin; William T Harrison; Simon W White; Isabelle Doan; Shelby N Harper; Patrick D Leidig; J Todd Purves
Journal:  Am J Physiol Renal Physiol       Date:  2019-12-23

9.  Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.

Authors:  Jae Hung Jung; Karen Ann McCutcheon; Michael Borofsky; Shamar Young; Jafar Golzarian; Balaji Reddy; Tae Young Shin; Myung Ha Kim; Vikram Narayan; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2020-12-19

10.  Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.

Authors:  Juan Va Franco; Luis Garegnani; Camila Micaela Escobar Liquitay; Michael Borofsky; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.